GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Shin Nippon Biomedical Laboratories Ltd (TSE:2395) » Definitions » Other Stockholders Equity

Shin Nippon Biomedical Laboratories (TSE:2395) Other Stockholders Equity : 円2,668 Mil (As of Dec. 2023)


View and export this data going back to 2004. Start your Free Trial

What is Shin Nippon Biomedical Laboratories Other Stockholders Equity?

Shin Nippon Biomedical Laboratories's Other Stockholders Equity for the quarter that ended in Dec. 2023 was 円2,668 Mil.

Shin Nippon Biomedical Laboratories's quarterly Other Stockholders Equity increased from Jun. 2023 (円706 Mil) to Sep. 2023 (円4,119 Mil) but then declined from Sep. 2023 (円4,119 Mil) to Dec. 2023 (円2,668 Mil).

Shin Nippon Biomedical Laboratories's annual Other Stockholders Equity increased from Mar. 2022 (円-2,621 Mil) to Mar. 2023 (円460 Mil) and increased from Mar. 2023 (円460 Mil) to Mar. 2024 (円4,861 Mil).

Shin Nippon Biomedical Laboratories Other Stockholders Equity Historical Data

The historical data trend for Shin Nippon Biomedical Laboratories's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shin Nippon Biomedical Laboratories Other Stockholders Equity Chart

Shin Nippon Biomedical Laboratories Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Other Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3,901.40 -105.67 -2,620.83 460.23 4,861.43

Shin Nippon Biomedical Laboratories Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 460.23 706.41 4,119.46 2,667.90 4,861.43

Shin Nippon Biomedical Laboratories Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

Shin Nippon Biomedical Laboratories Other Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Shin Nippon Biomedical Laboratories's Other Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Shin Nippon Biomedical Laboratories (TSE:2395) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Shin Nippon Biomedical Laboratories Ltd (TSE:2395) » Definitions » Other Stockholders Equity
Comparable Companies
TSE:2309 TSE:4694 TSE:4671 TSE:7707 TSE:3386 TSE:2397 TSE:6090 TSE:4544 TMO DHR SHSE:603259 IDXX IQV A XSWX:LONN MTD ICLR ILMN LH DGX
Traded in Other Exchanges
YB3:Germany
Address
8-1 Akashi-cho, Tokyo, JPN
Website
http://www.snbl.co.jp
Shin Nippon Biomedical Laboratories Ltd provides pre-clinical testing services in the pharmaceutical industry in Japan. The company provides a range of services such as pre-clinical and analysis studies, contracted clinical trials, SMO, CRO, translational research and cancer treatment.

Shin Nippon Biomedical Laboratories (TSE:2395) Headlines

No Headlines